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Abstract
Background: The aim of this study was to estimate the prevalence of HIV and other STIs, among MSM from Buenos Aires
(2007–2009).
Methods: Responding Driven Sampling was used for recruitment of MSM. Participants completed a structured web-based
survey and provided biological samples.
Results: A total of 496 MSM were studied for HIV, HBV, HCV, and T pallidum infections. Chlamydia and HPV diagnoses were
only performed in 98 and 109 participants, respectively. Prevalence of HIV was 17.3%, HBV 22.9%, HCV 7.5%, T pallidum
20.5%, HPV 83.5%, and C trachomatis 1.7%. In the year prior to the evaluation, 71% of the participants had had sex with men
and/or trans and women (MMW) while 29% had not had sex with women (MM). Comparing MM to MMW, prevalence of HIV
(30.7% vs. 11.9%, p,0.001), HBV (36.4% vs. 17.8%, p,0.001), T pallidum (32.1% vs. 15.7%, p,0.001), and HPV (88.3% vs.
70.4%, p=0.039) were significantly higher among MM, whereas no significant differences were found for HCV and C
trachomatis. The MM group had also significantly higher HIV incidence (5.60 vs. 4.28 per 100 persons-year, p=0.032). HPV
genotypes 16, 6, and 11 were the most frequently found; 40.7% of the MSM had more than one genotype and one high risk
genotype was detected in 43.6% of participants.
Conclusions: Both MM and MMW are at high risk of infection for HIV and other STIs. Rates of HIV, HBV, T pallidum and HPV
infections are higher in the MM group.
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Introduction
Men who have sex with men (MSM) have been shown to be at
disproportionate risk of HIV infection and prevalence rates of
HIV among this population are high: 11–20% in Latin American
countries and approximately 19% across major cities of the United
States [1–3]. Rates of other sexually transmitted infections (STI),
such as syphilis, gonorrhea, chlamydia, and Human papilloma
virus (HPV) are also high and increasing among MSM [4–7],
something worrisome given the association of these STIs with
other serious illnesses [1,7–11]. For example, HPV infection has
been shown to be high among MSM in several studies [7,12–14]
and has been associated with a variety of cancers in men, including
anal, penile and oral cancers. The incidence of anal and oral
cancers related to HPV is increasing in the general population and
is growing even faster among individuals who are immunocom-
promised because of HIV infection [15–17]. Recently, HPV
vaccination for adolescent women has been introduced in several
countries (including Argentina) with the aim of reducing the
incidence of cervical cancer [18]. However, vaccination has not
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impact that HPV infection has among men, in particular MSM.
In Argentina, the HIV epidemic is classified as concentrated,
with HIV prevalence higher than 5% in more than one defined
subpopulation and lower than 1% in pregnant women [19–20].
HIV prevalence among MSM in Buenos Aires has been estimated
at 14% [21–22]. Estimates of HIV incidence have ranged from
4%, using a cohort of MSM followed for one year, to 6% persons-
year, using STAHRS [22–24]. Prevalence of some STIs has also
been high, with Hepatitis B (HBV) at 38% and Treponema pallidum
at 17%. Rates of Hepatitis C (HCV) and Human T-Leukemia
Virus 1/2 (HTLV-1/2) infection were 1.9% and 0.3%, re-
spectively [25]. However, there have been no studies to date that
assess prevalence of other STIs such as HPV and Chlamydia
trachomatis in MSM in Argentina.
While previous studies in Argentina have provided a general
estimate of the prevalence and incidence of HIV and other STIs
among MSM, they were conducted using convenience samples
recruited through a gay-identified organization, which consisted
mostly of highly educated, gay-identified MSM. However, given
the diversity in sexual identities, partners, and behaviors among
MSM, establishing accurate estimates of HIV and STI prevalence
and incidence requires accessing hidden populations of MSM who
might not be reached through convenience sampling. In order to
reach a more representative sample of MSM, we used, for the first
time in Argentina, Responding Driven Sampling (RDS), a method
of data collection and statistical inference that uses social networks
to access hidden populations [26–27]. The aim of this study was to
investigate the prevalence of HIV and other STIs, including, for
the first time, HPV and Chlamydia trachomatis, among MSM from
Buenos Aires exploring the results according to the type of sex
partner. Given the association of certain HPV types and neoplastic
lesions, HPV genotyping was also included.
Methods
Study Population
The study took place in Buenos Aires, Argentina, between
November 2007 and July 2009. Recruitment was conducted using
RDS. For further details about the use of RDS in this study, we
refer the reader to Carballo-Dieguez et al [28]. Briefly, this
methodology consist of a technique that combines ‘‘snowball
sampling’’ with a mathematical model to compensate for non-
randomness of participant selection (for detailed information see
http://www.respondentdrivensampling.org). In our study, sixteen
seeds were recruited based on their purported large networks of
MSM acquaintances, likelihood of referring three of them to the
study, diversity of backgrounds, self-reported serostatus, sexual
identity, and availability. They underwent all study procedures
and were then given three recruitment coupons to pass to
members of their networks. Each subsequent participant was also
provided with three recruitment coupons to distribute in his
network, until the target number was reached. All participants
were offered a dual incentive (for participation and for each
eligible person recruited) thus producing chains of referrals that
move away from the initial seeds. All participants were asked to
report the number of people in their network who belonged to the
target population; this number was used to weight the provided
data.
Eligibility criteria included identifying as a man, being 18 years
or older, having had sex with men or male-to-female transvestite
(MFT) in the prior six months, having had sex with men or MFT
at least 10 times in his lifetime, residing in Buenos Aires city or its
suburban areas, having a coupon received from a prior participant
(not applicable to seeds), and agreeing to provide a blood sample
for HIV and other STI testing. Individuals previously diagnosed
for the pathogens studied were not excluded.
Ethics Statement
International and national ethical guidelines for biomedical
research involving human subjects were followed. This research
study received approval from a local Institutional Review Board
(IRB) (Comite ´ Independiente de Etica en Investigacio ´n (CIEI-FM-UBA),
Buenos Aires, Argentina) and the IRB of the New York State
Psychiatric Institute (New York City, USA), and was conducted in
compliance with all federal regulations governing the protection of
human subjects. All potential participants underwent an informed
consent procedure prior to entering the study and provided
written consent.
Study Procedures
All participants were seen at the offices of the NGO partner
(Nexo Asociacio ´n Civil). As part of the study, participants had to
complete a structured web-based survey, undergo a medical exam,
and provide biological samples for STIs diagnoses. During the
study visit, participants received HIV pre-test counseling. When
they returned two weeks later to receive test results, they also
received HIV post–test counseling and, when appropriate,
referrals for medical care. Those who tested HIV positive were
referred to the INBIRS for viral load and CD4 count. Patients with
a positive diagnosis for any of the other STIs were referred to
specific clinical centers. Treatment was offered to participants with
current T pallidum infection.
Samples Collection and STIs Diagnoses
A sample of anticoagulated blood was collected for determina-
tion of HIV, HBV, HCV and T pallidum infection. HIV diagnosis
was performed by means of ELISA and agglutination techniques
(Murex HIV Ag/Ab combination, Dartford, UK; SFD HIV K
PA, BIORAD, Marnes la Coquette, France) and confirmed by
Western Blot (Bioblot HIV-1 plus, BIOKIT, Barcelona, Spain).
Diagnosis of T pallidum infection was conducted using quantitative
VDRL (VDRL, Wiener Laboratorios, SAIC, Rosario, Argentina),
and microhemagglutination (TPHA, Biokit SA, Barcelona, Spain).
An indirect immunofluorescence test (FTA-abs, Inmunofluor
Biocientifica SA, Argentina) was used in the case of discordant
results. Markers of HBV infection were determined using ELISA
(HBsAg (V2) ABBOTT AxSYM SYSTEM; Core AxSYM
SYSTEM ABBOTT, Wiesbaden, Germany). A sample was
considered to be HBV positive if at least one of the markers was
found. To determine infection with HCV, anti-HCV was tested by
ELISA (HCV version V3.0, ABBOTT AxSYM SYSTEM;
Wiesbaden, Germany).
Tests for HPV and C trachomatis infection were offered to all
participants. Those who accepted were instructed on obtaining the
samples (auto sampling). Anal brushing was performed with
a cytobrush (Endocervical brush, Medisul, Argentina) and stirred
in a tube containing sterile Phosphate buffered saline. The brush
was removed and the tube was centrifuged at 1,500 rpm for 10
minutes. Supernatant was discarded and the pellet was kept at
220uC until processed. Cells were disrupted by proteinase K
digestion and tested by Polymerase Chain Reaction (PCR) for b-
globin gene to confirm the presence of the adequate DNA
template. DNA was used for HPV and C trachomatis detection and
genotyping. For HPV, PCR using GP5+ and biotin-labeled GP6+
generic HPV primers was performed to amplify 140 bp in the L1
viral regio ´n. GP-PCR positive samples were typed by reverse line
blot hybridization using 6, 11, 16, 18, 26, 31, 33, 34, 35, 39, 40,
HIV and HPV Infection among MSM from Buenos Aires
PLoS ONE | www.plosone.org 2 June 2012 | Volume 7 | Issue 6 | e3983442, 43, 44, 45, 51, 52, 53, 54, 55, 56, 57, 58, 59, 61, 66, 68, 70, 71,
72, 73, 81, 82, 83, 84 and CP6108 type-specific oligoprobes.
Positive reactions were revealed by chemiluminescence using
AmershamTM ECLTM Detection Reagents according to man-
ufacturer recommendations (GE Healthcare, Little Chalfont, UK).
CaSki and HeLa cell DNAs (which harbor HPV 16 and 18
sequences respectively) were used as positive controls [29]. The
ompA gene of C trachomatis was amplified using a semi-nested PCR
[30]. An approximately 1-kb fragment of the ompA gene was
amplified using the primers SERO1A and SERO2A. DNA of
C.trachomatis L2/BU/434 (kindly provided by Sezione di
Microbiologia DMCSS, Universita ` degli Studi di Bologna,
Bologna, Italy) and mock-infected cells were included as positive
and negative controls, respectively. One microliter of the first-
round PCR product was used for the semi-nested PCR performed
with the same reagents and conditions, except for the primers,
which were SERO2A, and one nested primer: PCTM3. The
second-round PCR products were checked on ethidium bromide-
stained 1.5% agarose gels. This semi-nested PCR was able to
detect 1–10 inclusion-forming units. C. trachomatis genotyping
was carried out in all PCR-positive samples by restriction fragment
length polymorphism (RFLP).
Incidence Estimation
HIV-positive plasma samples were tested using a modified or
‘‘detuned’’ version of an HIV-1 enzyme immunoassay (Vironos-
tika HIV-1 Microelisa System; bioMerieux Inc, North Carolina,
USA) in order to classify samples as potential recent infections
(time of infection less than 4–6 months prior to sample collection)
or longstanding infections. For this, the STARHS strategy was
performed, as previously described [22,24].
To estimate incidence, we used the formula provided by
McWalter and Welte [31]:
I~ R{FRR   P ðÞ = 1{FRR ðÞ   w   N ðÞ
where N is the number of HIV negative individuals in the survey,
P is the number of HIV positive individuals in the survey, R is the
number of individuals classified as recent on the assay, w is the
mean assay duration specified in units of years, and FRR is the
false recent rate of the assay which is the number of individuals
who are incorrectly identified as recent divided by P. A number of
incidence formulas are available for estimating incidence, but we
chose to use McWalter and Welte’s method since it is currently
recommended by WHO and the CDC.
Statistical Analysis
For all analyses, data were weighted prior to analyses using
SPSS. Weights were calculated as the inverse of the participant’s
personal network size (PNS). This value was then multiplied by the
sample size (N) divided by the sum of weights (gw). The weighting
formula is then:
1=PNS ðÞ   N=
X
w
  
This produces results that reflect the original sample size of 500.
All results presented in this manuscript are based on weighted
data. Two-group comparisons (men who have sex with women vs.
not; HIV+ vs. HIV-) were conducted using logistic regression
analyses (or t-tests for one continuous variable: number of STIs).
Finally, multivariate logistic regression analyses were conducted to
assess the association between HIV infection and other STIs,
adjusting for type of partner (a dichotomous variable indicating sex
with women in the past year vs. not).
Results
Characteristics of the Study Group
A total of 500 MSM where recruited into the study. Participants
were young (M=30.5 years, SD=11.5), mostly unemployed
(30%) or temporarily employed (32%) and many (66%) partici-
pants had not completed high school. Most participants were
single (78%) and lacked health insurance (79%). For a more
detailed description of the population please see Carballo Dieguez
et al [28].
Sexual Partners and Sexual Identity
By eligibility criteria, all men had had sex with another man at
least once in the prior six months and at least 10 times in their life.
Eighty-eight percent of participants reported having had sex with
men in the prior two months, 66% with women, and 47% with
male to female transvestites (partnership types may overlap). Most
participants (88%) had more than one sexual partner in the past
two months. Thirty-six percent identified as bisexual, 25% as gay,
22% as heterosexual and 17% as ‘‘other’’.
STIs Prevalence
A total of 496 MSM were studied for HIV, HBV, HCV and T
pallidum infections (four blood samples were not available for the
tests). Only 131 participants agreed to undergo an anal brushing
auto sampling for Chlamydia and HPV. Because of methodolog-
ical issues, diagnoses were performed in 98 and 109 participants,
respectively. As per Table 1, prevalence of HIV was 17.3%, HBV
22.9%, HCV 7.5%, T pallidum 20.5%, HPV 83.5% and C
trachomatis 1.7%.
Due to differential risk of STI transmission, we compared
participants whose sexual partners in the past year included
women (MMW, 71%) to those who did not (MM, 29%).
Compared to MMW, MM had significantly higher prevalence of
HIV (30.7% vs. 11.9%, p,0.001), HBV (36.4% vs. 17.8%,
p,0.001), T pallidum (32.1% vs. 15.7%, p,0.001) and HPV
(88.3% vs. 70.4%, p=0.039), whereas no significant differences in
prevalence were found for HCV and C trachomatis (Table 1). As
seen in Table 2, 37% of the men had at least one infection, and
MM were more likely than MMW (55% vs. 30.6%, p,0.001) to
have at least one infection.
HIV positivity was significantly associated with HBV, HCV and
T pallidum infections in univariate analysis for the entire sample
(Table 3) and when stratified by partner type (Table 4). Finally,
multiple logistic regression analysis (not shown) adjusted by type of
partner (sex with women in past year vs. not) showed that
individuals with HIV were 10.7 times more likely to have HBV
(95% CI=6.2–18.4, p,.001), 19.3 times to have HCV (95%
CI=8.7–43.0, p,.001) and 5.6 times to have T pallidum infection
(95% CI=3.3–9.5, p,.001). No significant association was found
for HPV infection and statistics cannot be calculated for C
trachomatis.
HIV Incidence
The overall incidence rate was 4.53 per 100 persons-year for the
whole group. Incidence in the MM was significantly higher than in
the MMW group (5.60 vs. 4.28 per 100 persons-year, p=0.032).
HPV Genotyping
HPV genotyping was feasible in 80 samples. Genotypes 16
(24.5%), 6 (28.6%) and 11 (21.0%) were the most frequently
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(10.4%), 53 (2.6%), 61 (4.6%), 81 (3.3%), 40 (4.1%), 42 (4.2%), 44
(4.0%), 52 (3.6%), 70 (6.3%), 83 (2.1%), 43 (1.8%), 51 (4.5%), 54
(3.9%), 72 (2.1%), cand62 (1.4%), CP6108 (4.5%), 35 (0.7%), 39
(1.8%), 71 (0.5%), 82 (3.6%) and 84 (1.2%) were also indentified.
Co-infection with different HPV genotypes was very frequent
with 40.7% of the individuals having more than one genotype
(21.4% have two, 11.6% have three and 7.7% have four or more).
Following Mun ˜oz classification [32], 43.6% of the volunteers have
almost one high risk genotype. No significant differences were
observed in the quantity of different HPV types or the presence of
high risk types between MM and MMW.
Discussion
A high prevalence of HIV and other sexually transmitted
infections such as HBV, T pallidum and HPV was observed among
a diverse sample of MSM in Buenos Aires in which many did not
identify as gay and also have sex with women and transvestites.
The diversity of MSM recruited for this study through the use of
RDS allowed us to examine how sexual partner type (e.g. having
sex also with women) is associated to prevalence of STIs.
The rates of HIV and STIs found in this study were much
higher than those in previous studies with MSM population [25].
The exception to this is HBV, which has remained relatively
constant. One possible reason for this could be the access to the
HBV vaccine, available in Argentina since 1982 and which has
been implemented as mandatory for babies and adolescents (11
years old) since 2000 [33]. The increase in HIV and STI
prevalence rates mirrors reports from other countries [34–35].
This has been attributed to the availability of more effective and
less debilitating treatments for HIV and a decrease in fear of
acquiring or transmitting HIV, which has contributed to increased
sexual risk behavior [36]. For example, serosorting, having
unprotected sexual intercourse based on concordant HIV status,
is practiced as a risk reduction strategy by increasing numbers of
MSM. Even when some studies reported a small HIV risk
reduction [37], this strategy does not consider the transmission of
other STIs [38]. The expanded survival of HIV patients also
increases the pool of HIV infected MSM in the community.
Table 1. STIs prevalence according to type of partner among 496 MSM recruited through RDS in Buenos Aires, 2007–2009.
MM (N=140) MMW (N=338) Total (N=496)
n/total
Prevalence
(95%CI) n/total
Prevalence
(95%CI) n/total Prevalence (95%CI) OR (95% CI) p
HIV 43/140 30.7% (23.2%,
39.1%)
40/335 11.9% (8.7%,
15.9%)
85/494 17.3% (14.0%, 20.8%) 0.31 (0.19–0.50) ,.001
HBV 51/140 36.4% (28.5%,
45.0%)
60/337 17.8% (13.9%,
22.3%)
114/496 22.9% (19.9%, 26.9%) 0.38 (0.24–0.59) ,.001
HCV 7/140 5.0% (2.0%,
10.0%)
30/338 8.9% (6.1%,
12.4%)
37/496 7.5% (5.3%, 10.1%) 1.85 (0.79–4.35) .157
T. pallidum 45/140 32.1% (24.5%,
40.6%)
53/337 15.7% (12.0%,
20.1%)
102/496 20.5% (17.1%, 24.4%) 0.39 (0.25–0.62) ,.001
HPV 68/77 88.3% (79.0%,
94.5%)
19/27 70.4% (49.8%,
86.3%)
91/109 83.5% (75.2%, 89.9%) 0.30 (0.10–0.89) .030
C. trachomatis 2/70 2.9% (0.4%,
9.9%)
0/25 0.0% (0.0%,
13.7%)
2/98 1.7% (0.3%, 7.2%) 0.00 (0.00–0.00) .998
MM: participants whose sexual partners did not include women; MMW: participants whose sexual partners included women. Note: the total column includes men who
could not be placed in either group due to missing data.
doi:10.1371/journal.pone.0039834.t001
Table 2. Number of STIs according to type of partner.
Number of STIs MM (N=140) MMW (N=337) Total (N=496) T-test p
n/total % (95%CI) n/total % (95%CI) n/total % (95% CI)
0 63/140 45.0% (36.6%,
53.6%)
234/337 69.4% (64.2%,
74.3%)
313/496 63.0% (58.7%, 67.4%) ,.001
1 31/140 22.1% (15.6%,
29.9%)
53/337 15.7% (12.0%,
20.1%)
85/496 17.1% (13.9%, 20.8%)
2 24/140 17.1% (11.3%,
24.4%)
23/337 6.8% (4.4%,
10.1%)
48/496 9.7% (7.2%, 12.6%)
3 21/140 15.0% (9.5%,
22.0%)
23/337 6.8% (4.4%,
10.1%)
45/496 9.1% (6.7%, 12.0%)
4 1/140 0.7% (0.0%,
3.9%)
4/337 1.2% (0.3%,
3.0%)
5/496 1.1% (0.3%, 2.3%)
MM: participants whose sexual partners did not include women; MMW: participants whose sexual partners included women. Note: the total column includes men who
could not be placed in either group due to missing data.
doi:10.1371/journal.pone.0039834.t002
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persons/year) also suggests that HIV is currently been transmitted
in the group. Even when the best studies to estimate HIV
incidence are follow up cohort studies, the incidence value
detected here using STAHRS, is in agreement with previous
reports from Argentina (using both kind of strategies) [22–24].
This study reports C trachomatis infection prevalence among
MSM for the first time in Argentina. The 2.9% prevalence of C
trachomatis anal infection detected among MM group is higher than
that observed in STI symptomatic adult patients (1.85%) [39], but
lower than that detected among male-to-female transvestite sex
workers (TSWs) (5.0%) [40]. Although C trachomatis infection is less
prevalent than the other STIs tested here, it is essential that the
prevalence of this infection be monitored, as studies have reported
increasing rates of infection among MSM. This is concerning
since, even as a non-ulcerative and frequently asymptomatic
infection, it has been associated with increased risk for HIV
infection [7]. The limited number of participants who agreed to
anal brushing limits the generalizability of our findings. Possible
self-exclusion by participants with anal lesions or individuals with
negative experiences during previous test for anal infections could
bias the sample collection and the prevalence results.
The high prevalence of HPV infection detected in our study is
consistent that from a recent study in Argentina among TSWs
which found an HPV prevalence of 97.4% [40]. The results
presented here are also similar to those from other countries,
which found HPV prevalence around 90–96% in HIV positive
individuals and from 40 to 60% among HIV negative MSM
[12,14,41]. Some authors have proposed that lesions related with
HPV may increase cell-mediated immune response that could
facilitate HIV acquisition [42]. The range of HPV types detected
in anal samples was wide, with 28 different types identified, but
three types (16, 6 and 11) reached 65% of the infections. The
prevalence of high-risk genotypes (44.5%) was lower to what was
found in TSWs from Argentina where high risk genotypes were
detected in 82.5% of them [40]. The high frequency of men
infected with HPV 16 is worrying given that this HPV type is
considered to cause more than 70% of anal cancers [43]. This
frequency rises from 24 to 44% considering all high-risk HPV
genotypes [32]. Other important finding related to HPV infection
is the high frequency of multiple infections, with approximately
40% of men carrying more than one HPV type. Although, the
impact of the infection with multiple genotypes on the persistence
and on progression to intraepithelial abnormalities has not been
well established, some authors have found an increased risk for
anal intraepithelial neoplasia (AIN) in men with higher numbers of
HPV genotypes [43]. Early diagnosis and treatment of patients
with HPV infection is important because this infection causes
substantial distress even in its benign manifestations [44]. HPV
vaccination is mandatory in Argentina for adolescent girls [18];
however there are no specific recommendations for men, even
when international organizations (Advisory Committee on Immu-
nization Practices (ACIP), CDC) recommended routine vaccina-
tion for all males. MSM are at higher risk for infection with HPV
types 6, 11, 16, and 18 and associated conditions, including genital
warts and anal cancer. In this context ACIP recommends routine
vaccination of MSM with the Quadrivalent Human Papilloma-
virus Vaccine (HPV4) as for all males, and vaccination through
age 26 years for those who have not been vaccinated previously or
who have not completed the 3-dose series [45]. In light of the high
prevalence detected in our study, HPV vaccination among young
men could be beneficial and should be also routinely offer to male
patients who engage in high risk behavior. Results from this study
show that both MM and MMW are at high risk for HIV and other
STIs. However, stratification according the type of sex partner
provides evidence that the MMW group had lower frequency of
infection for HIV, HBV, T pallidum and HPV than the MM group.
A significantly lower HIV incidence was also detected among
MMW. Though no risk factor analysis was done in order to
explain these differences, the possible reasons could be the lower
prevalence of all these agents in women and the lower frequency of
transmission from women to men. Furthermore, it may be
hypothesized that these MMW have sex with other men less
frequently than those men who only have sex with other men.
Also, the MM group may be more exposed to these infections due
to the high frequency detected and that STIs are more easily
transmitted through anal contact. Even though HIV, HBV, T
pallidum and HPV prevalence are lower among MMW, pre-
valences are high and constitute a group that should be considered
with special attention in prevention campaigns. Some studies
indicate that individuals exhibiting bisexual behavior could be
a bridge population between MSM and women [46]. Several
authors postulate that those men who have sex with men and
women have their homosexual activity highly secretive and use of
condom may be irregular with both. Condom use may be more
irregular with men when intercourse is done under secretive
conditions, and when intercourse is done with the female partner
condom use may be irregular in order to avoid suspicion of
infidelity [47].
The use of RDS allows us to study a sector of the MSM
population (those who also have sex with women and/or trans,
mostly not identified as ‘‘gay’’) that was insufficiently represented
in most previously convenience samples studies. As we reported
[28], RDS appears to have been effective in reaching a ‘‘hidden’’
Table 3. Association between HIV and other STIs.
Total
(N=496)
HIV positive HIV negative OR P
n/total Prevalence (95%CI) n/total Prevalence (95%CI) (95% CI)
HBV 58/86 67.4% (56.5%, 77.2%) 56/409 13.7% (10.5%, 17.4%) 12.97 (7.61–22.10) ,.001
HCV 25/86 29.1% (19.8%, 39.9%) 13/410 3.2% (1.7%, 5.4%) 12.80 (6.16–26.59) ,.001
T. pallidum 44/85 51.8% (40.7%, 62.7%) 56/409 13.7% (10.5%, 17.4%) 6.76 (4.07–11.26) ,.001
HPV 36/39 92.3% (79.1%, 98.4%) 55/69 79.7% (68.3%, 88.4%) 2.73 (0.79–9.47) .114
C. trachomatis 0/34 0.0% (0.0%, 10.3%) 2/64 3.1% (0.4%, 10.8%) 0.00 (0.00–0.00) .998
doi:10.1371/journal.pone.0039834.t003
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RDS is a very new recruitment strategy and there are some
concerning issues about assess to network size and data analysis
that need further study [48].
In summary, when compared with general population, alarm-
ingly high rates of all STIs tested were detected among MSM.
Therefore, two very significant observations should be taken in
consideration as result of this study. First, the high prevalence of
HPV detected deserves to be stressed in discussions about vaccine
implementation. It must also be highlighted that prevention of
HPV infection through vaccination could help to prevent not only
HPV related diseases but also HIV acquisition. Second, it was
clear that different partnership types included under the MSM
category should be carefully studied because they may be
associated with different STI frequencies. In this sense, interven-
tions for HIV and other STIs reduction strategies should consider
the variety of sexual practices in which MSM engage.
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